Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126672) titled 'Real-world Study of Idebenone in the Treatment of Leber's Hereditary Optic Neuropathy' on June 13.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Peking Union Medical College Hospital

Condition: Leber's Hereditary Optic Neuropathy

Recruitment Status: Recruiting

Phase: 4

Date of First Enrollment: 2026-06-30

Target Sample Size: case series:50;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=324310

Disclaimer: Curated by HT Syndication....